Try our mobile app
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen” or “the Group”)
Appointment of Directors
In compliance with Section 3.59 of the Listings Requirements of the JSE Limited, the Aspen Board of Directors
confirm the following appointments, with effect from 07 March 2024:
- Ms Neo Dongwana as an independent non-executive director and member of Aspen’s Audit & Risk
Committee; and
- Mr Reginald Haman (prescribed officer and member of Aspen’s Social and Ethics Committee) as an
executive director.
Ms Dongwana currently serves as a non-executive director on the Nedbank Group Limited board. She
previously served as a non-executive director and chairperson of Barloworld Limited and as a non-executive
director on the boards of, inter alia, Mpact Limited and AVI Limited. Ms Dongwana is a Chartered Accountant
(SA) by profession, with an MCom (Accounting) (University of Witwaterstrand) and BCom Hons (Financial
Analysis and Portfolio Management) (University of Cape Town). She is also a member of the African Women
Chartered Accountants.
Mr Haman joined Aspen in May 2020 as the Group Chief Corporate Services Officer and is a member of
Aspen’s Group Executive Committee. His responsibilities comprise leading Aspen’s portfolio of Group
enablement, governance and shared service functions (including technology, people, strategic business
processes, ESG and information). Mr Haman has extensive experience as a business executive and non-
executive director in various industries, including mining and financial services. He holds an MBA (Gordon
Institute of Business Science) and other relevant business qualifications.
We look forward to Ms Dongwana and Mr Haman’s contribution to the Group and wish them every success
in their respective new roles.
Durban
08 March 2024
Sponsor:
Investec Bank Limited
